ClinConnect ClinConnect Logo
Search / Trial NCT05972772

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Scrub Typhus Typhus, Endemic Flea Borne

ClinConnect Summary

The Rickettsia Clearance Study is a clinical trial aimed at understanding how well certain antibiotics work for treating infections caused by rickettsial bacteria, specifically murine typhus and scrub typhus. These diseases can be serious and are often hard to diagnose. The study is looking for adult participants who test positive for either murine typhus or scrub typhus, can take oral medications, and are willing to stay in the hospital for at least 36 hours. It's important that participants are not pregnant or breastfeeding, and they shouldn't have had recent treatments with certain antibiotics before joining the trial.

If you participate in this study, you will receive treatment and be closely monitored by healthcare professionals. The goal is to learn more about the effectiveness of different antibiotics and to find better ways to manage these infections. This research could help improve treatment options for many people suffering from these diseases in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age above or equal 18 years
  • Able to take oral medication
  • Rapid test positive for murine typhus or scrub typhus
  • Agrees to stay in hospital for at least 36 hours and to attend for scheduled follow up visits
  • Written informed consent to participate in the study
  • A negative urinary pregnancy test for all women of child-bearing age
  • Exclusion Criteria:
  • Pregnancy or breast feeding
  • Previous allergic reaction to doxycycline or azithromycin
  • Received more than one dose of chloramphenicol, doxycycline, tetracycline, fluoroquinolones, rifampicin or azithromycin during this hospital admission or more than one dose of any of these drugs in the week before admission
  • Contraindication to doxycycline: severe hepatic impairment, known SLE
  • Contraindication to azithromycin: sever hepatic impairment
  • * Severe typhus defined as the presence of one or more of the following:
  • 1. Reduced level of consciousness
  • 2. Clinical jaundice
  • 3. Shock (BP systolic \<80 mmHg)
  • 4. Unable to take oral medication
  • 5. Radiological evidence of pneumonia
  • 6. Clinical evidence for meningitis/encephalitis or the need of LP
  • 7. Alternative diagnosis confirmed that explains the presenting symptoms
  • 8. Any other syndrome which in the opinion of the admitting doctor constitutes severe typhus (reason must be stated)

About Lao Oxford Mahosot Hospital Wellcome Trust Research Unit

The Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit is a leading clinical research institution based in Vientiane, Laos, dedicated to advancing global health through high-quality research. It operates at the intersection of clinical medicine and epidemiology, focusing on infectious diseases, tropical medicine, and public health challenges in Southeast Asia. Supported by the Wellcome Trust, the unit collaborates with international and local partners to conduct innovative clinical trials, promote capacity building, and enhance healthcare delivery. Its commitment to ethical research practices and community engagement ensures that findings contribute to improving health outcomes in the region and beyond.

Locations

Vientiane, Vientaine, Lao People's Democratic Republic

Vientiane Province, , Lao People's Democratic Republic

Patients applied

0 patients applied

Trial Officials

Weerawat Phuklia, PhD

Principal Investigator

Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported